A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial ...

Fast food giant McDonald’s has thwarted councils’ attempts to block new stores by claiming they can promote “healthier lifestyles”, an investigation reveals. Experts warned that councils are facing a ...

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

Viking Therapeutics stock plunged late Wednesday on an earnings report that included mostly incremental updates for its ...

High ultraprocessed food (UPF) consumption during early childhood is associated with obesity development, primarily in males, ...

Body weight and body mass index alone are not enough to predict whether someone will develop a metabolic disease. A new atlas of cells in fat tissue could help to explain why some overweight people ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Michelle Obama has left a very important legacy in the United States, especially in the health sector with medical care and ...

As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC. New research from the ...

Neurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably have the same ...

A new study suggests that diets high in fast food, processed red meat, and soda but low in fruits and vegetables may be linked to faster biological aging.

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.